In vitro and in vivo studies of plant-produced Atezolizumab as a potential immunotherapeutic antibody
Abstract Immune checkpoint inhibitors are a well-known class of immunotherapeutic drugs that have been used for effective treatment of several cancers. Atezolizumab (Tecentriq) was the first antibody to target immune checkpoint PD-L1 and is now among the most commonly used anticancer therapies. Howe...
Na minha lista:
| Principais autores: | , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Nature Portfolio
2023-08-01
|
| Serier: | Scientific Reports |
| Online adgang: | https://doi.org/10.1038/s41598-023-41510-w |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|